Study Evaluating HKI-272 Administered to Healthy Subjects

NCT00366600 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: neratinib

Sponsor

Puma Biotechnology, Inc.